rx 821002 has been researched along with mirtazapine in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (mirtazapine) | Trials (mirtazapine) | Recent Studies (post-2010) (mirtazapine) |
---|---|---|---|---|---|
317 | 0 | 45 | 1,538 | 324 | 646 |
Protein | Taxonomy | rx 821002 (IC50) | mirtazapine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0851 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.2239 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.1995 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 3.1623 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Transporter | Rattus norvegicus (Norway rat) | 0.26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Fuster, MJ; García-Sevilla, JA | 1 |
1 other study(ies) available for rx 821002 and mirtazapine
Article | Year |
---|---|
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |